Correction to: The clinical usage of liposomal amphotericin B in patients receiving renal replacement therapy in Japan: a nationwide observational study

Clin Exp Nephrol. 2021 Mar;25(3):288. doi: 10.1007/s10157-020-02004-5.

Yoko Obata¹, Takahiro Takazono^{2

3}, Masato Tashiro^{2

4}, Yuki Ota⁵, Tomotaro Wakamura⁶, Akinori Takahashi⁷, Kumiko Sato⁷, Taiga Miyazaki^{2

3}, Tomoya Nishino⁵, Koichi Izumikawa^{2

4}

¹ Department of Nephrology, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan. yobata-ngs@umin.ac.jp.
² Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan.
³ Department of Respiratory Medicine, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan.
⁴ Nagasaki University Infection Control and Education Center, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan.
⁵ Department of Nephrology, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan.
⁶ Medical Affairs Division, Sumitomo Dainippon Pharma Co., Ltd, 1-13-1 Kyobashi, Chuo-ku, Tokyo, 104-8356, Japan.
⁷ Deloitte Tohmatsu Consulting LLC, Marunouchi Nijubashi Building, 3-2-3 Marunouchi, Chiyoda-ku, Tokyo, 100-8361, Japan.

No abstract available

Publication types